InvestorsHub Logo
Followers 34
Posts 2681
Boards Moderated 0
Alias Born 10/28/2013

Re: TrueTrades post# 9298

Tuesday, 07/28/2015 9:30:09 AM

Tuesday, July 28, 2015 9:30:09 AM

Post# of 481852
On that slide Anavex 2-73 is deliberately dosed low enough to show no effect on it's own, according to Missling. The purpose of that test and chart is to highlight the synergy issue with Donepezil.

At least that was Missling's explanation during the 27th Annual Roth Conference Presentation, March 2015. It is slide 18 and his audio explaining it is from 16:18 through 17:42.

I am glad you asked. That chart bothered me a great deal too when I saw it during the presentation. I heard his explanation but didn't really understand what he was saying, and was a little worried it was BS. But listening to it again, it makes total sense. That doesn't gauruntee that it is not BS, but it makes me feel a lot better. I have to decide whether to believe him, and I have chosen to believe him on this.

I was out of bullets last night so could not reply.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News